AIM ImmunoTech Inc (AMEX:AIM) has a beta value of 0.36 and has seen 2.12 million shares traded in the last trading session. The company, currently valued at $8.87M, closed the last trade at $0.13 per share which meant it lost -$0.01 on the day or -6.93% during that session. The AIM stock price is -376.92% off its 52-week high price of $0.62 and 0.0% above the 52-week low of $0.13. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.51 million shares traded. The 3-month trading volume is 991.95K shares.
The consensus among analysts is that AIM ImmunoTech Inc (AIM) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
AIM ImmunoTech Inc (AMEX:AIM) trade information
Sporting -6.93% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the AIM stock price touched $0.13 or saw a rise of 18.75%. Year-to-date, AIM ImmunoTech Inc shares have moved -34.85%, while the 5-day performance has seen it change -12.36%. Over the past 30 days, the shares of AIM ImmunoTech Inc (AMEX:AIM) have changed -31.96%. Short interest in the company has seen 0.91 million shares shorted with days to cover at 1.16.
AIM ImmunoTech Inc (AIM) estimates and forecasts
The company’s shares have lost -52.89% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 42.86% over the past 5 years.
AIM Dividends
AIM ImmunoTech Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
AIM ImmunoTech Inc (AMEX:AIM)’s Major holders
Insiders own 9.55% of the company shares, while shares held by institutions stand at 7.29% with a share float percentage of 8.06%. Investors are also buoyed by the number of investors in a company, with AIM ImmunoTech Inc having a total of 35.0 institutions that hold shares in the company. The top two institutional holders are ARMISTICE CAPITAL, LLC with over 4.08 million shares worth more than $1.52 million. As of 2024-06-30, ARMISTICE CAPITAL, LLC held 7.718% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 1.99 million shares as of 2024-06-30. The firm’s total holdings are worth over $0.74 million and represent 4.021% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . As of Sep 30, 2024 , the former fund manager holds about 1.91% shares in the company for having 1.31 shares of worth $0.17 million while later fund manager owns 620.23 shares of worth $80009.0 as of Sep 30, 2024 , which makes it owner of about 0.90% of company’s outstanding stock.
